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Over a 7-year period, 5.8% (n = 210) of patients who underwent coronary 
artery bypass grafting at our institution had severely impaired global left 
ventricular function with an ejection fraction of 20% or less. Mean age at 
operation was 66 years (+0.7; standard error), and 76% of patients were 
male. Primary indications for operation were unstable angina (73 patients, 
35%), return of symptoms with previous bypass grafting (41 patients, 20%), 
congestive heart failure with reversible ischemia (55 patients, 26%), and 
recurrent ventricular arrhythmias (41 patients, 20%). Overall, actuarial 
survival (n = 210) was 82%, 79%, and 73% at 1, 2, and 5 years. Risk of death 
was highest early after the operation, and then declined rapidly to a 
constant level. Patients who did not receive retrograde coronary sinus 
cardioplegia (p = 0.05), older patients (p = 0.004), and those with 
preoperative ventricular arrhythmias (p = 0.003) or renal failure (p < 
0.0001) had an increased risk of death early after operation. Patients with 
congestive symptoms and those requiring extensive or redo bypass grafting 
(p = 0.02) were found to be at an increased risk of death throughout he 
follow-up period. When the number of distal anastomoses performed 
increased, survival was found to decrease (p < 0.003), and to a greater 
extent in women than in men (p = 0.02). Of the four primary indications for 
operation, unstable angina yielded the highest risk-adjusted survival. 
Successful results after surgical revascularization in patients with severe 
impairment of ventricular function can be achieved by careful patient 
selection and management. (J Thorac Cardiovasc Surg 1996;111:1001-12) 
R evascularization of ischemic myocardium in pa- tients with severely impaired global left ventric- 
ular (LV) function remains a surgical challenge. 
Despite advances in surgical technique and myocar- 
dial protection, perioperative mortality and morbid- 
ivy remain high 1-3 and long-term survival is poor. 4 
Death often results from progression of preopera- 
tive symptoms of congestive heart failure (CHF) 4-7 or 
ventricular arrhythmias, 3' s, 9 even though revascular- 
ization may result in initial improvement. 4-6° 10-13 
Because alternative surgical treatments (i.e., 
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transplantation and cardiomyoplasty) are limited 14 
and the results of medical therapy are often unsat- 
isfactory, 1 coronary artery bypass grafting (CABG) 
is often the only available treatment hat will im- 
prove symptoms and longevity. 2'5, 10, 15 To quantify 
survival after CABG in these patients in whom the 
risk is high, and to characterize those most likely to 
benefit, we conducted a retrospective study. 
Patients and methods 
Patient selection. Between January 1, 1987, and De- 
cember 31, 1992, 3621 patients underwent CABG at our 
institution. This study is based on the 210 patients (5.8% 
of total) with severe impairment of global LV function 
who met the following criteria: (1) an LV ejection fraction 
of 20% or less, as assessed by area/length measurement on
biplane LV cineangiogram; (2) evidence of reversible 
ischemia in the distribution of one or more major coro- 
nary arteries on dipyridamole thallium scintigraphy; and 
(3) evidence of operable coronary artery disease (CAD) 
on coronary angiography. Patients with an LV aneurysm 
(n = 11), severe segmental dysfunction with scar on 
thallium scan (n = 3), and those with a grossly dilated 
cardiomyopathy (LV end-diastolic dimension >70 mm by 
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Tab le  I. Preoperative clinical details 
All patients ACC ACC + RCSC 
(n = 210) (n = 103) (n = 107) 
No. % No. % No. % p< 
Age (mean 66 _+ 0.7 yr) >70 yr 85 40.51 29 20 46 28 0.2 
Female 51 24.3 21 20 30 28 0.2 
Male 159 75.7 81 78.6 78 72.9 0.9 
Coronary risk factors 
Hypertension 119 56.6 55 53 64 60 0.3 
Diabetes mellitus 43 20.5 20 19.4 23 21.5 0.1 
Smoking 92 43.8 42 40.7 50 46.7 
Family history 44 20.95 23 22 25 24 0.8 
Hyperlipidemia 91 43.3 50 49 41 38 0.1 
Clinical presentation 
Unstable angina 43 19 18 17.5 23 22 0.5 
Recent myocardial infarction 30 14.3 16 15.5 17 23 0.97 
Recurring angina after previous CABG 41 19 16 15.5 6.25 23 0.2 
Stable angina--class IV 50 25 25 24.3 25 23.3 0.3 
CHF with reversible ischemia 55 26.2 28 27 27 25 0.7 
Ventricular arrhythmias (VT/VF) 41 19.52 21 20 20 18.7 0.8 
Peripheral vascular disease 15 7.1 10 9.8 5 4.7 0.2 
Cerebrovascular disease 13 6.2 7 6.9 6 5.6 0.7 
Previous cerebrovascular ccident 10 4.7 5 4.8 4 3.7 0.1 
Chronic obstructive pulmonary disease 25 11.9 16 15.5 9 8.4 0.2 
Chronic renal failure (dialysis) 9 4.3 6 5.8 3 2.8 0.3 
ECG, Holter monitor, and echocardiographic findings 
Old myocardial infarction 60 28.57 28 27 32 30 0.2 
Dilated cardiomyopathy (LVEDD <70 ram) 41 19 20 19.4 21 19.6 0.2 
Cardiac catherization and LV function 
Left main coronary stenosis 28 13.3 12 11.6 15 14 0.8 
Triple vessel disease 210 100 103 100 107 100 - -  
IABP support 44 21 25 24 19 17.7 0.2 
CABG, Coronary artery bypass graft; CHF, congestive cardiac failure; VT/VF, ventricular tachycardia/ventricular fibrillation; ECG, electrocardiographic; 
LVEDD, left ventricular end-diastolic dimension; LE left ventricular; IABP, intraaortic balloon pump; ACC, antigrade cardioplegia; RCSC, retrograde 
cardioplegia. 
Table I I .  Preoperative hemodynamic  and echocardiographic f indings in 210 patients 
Subgroup I Subgroup H Subgroup III Subgroup IV 
0l = 73) (n = 41) (n = 55) (n - 41) 
LVEDD (cm) 5.4 _+ 0.6 5.2 + 0.7 6 + 0.8* 5.6 _+ 0.7 
Echo, all patients 
Mean PASP (ram Hg) 29 _+ 3 28 ~+ 3 46 + 0.8~ 31 + 2 
Mean PCWP (ram Hg) 13 _+ 2 14 -+ 2.4 17 -+ 2.6 14 _+ 1.6 
LVSWI (gm/m/m 2) 19 _+ 2 23 -+ 1.6 17 -+ 2.8 22 _+ 2 
RVSWI (gm/m/m 2) 4.8 _+ 0,2 4.2 _+ 0.4 3.2 -+ 0.6 3.8 _+ 0.4 
SVRI (dyne • sec • cm -5) (median) 1600 1500 1360 1700 
LVEDD, Left ventricular End-Diastolic dimension; PASP, pulmonary artery systolic pressure; PCWP, pulmonary capillary wedge pressure; LVSWI, left 
ventricular stroke work index; RVSWI, right ventricular stroke work index; SVRL, systemic vascular resistance index. 
*Subgroup III versus ubgroup II, p < 0.03. 
tSubgroup III versus other subgroup,  < 0.05. 
echocardiography)  (n = 3) were excluded f rom this series. 
Preoperat ive pat ient  characterist ics are summar ized in 
Table I. 
Indications for revascularization. Pat ients were classi- 
fied as having one of four primary indications for CABG:  
unstable or post infarct ion angina (subgroup I, n = 73), 
recurrent  angina after previous myocardial  revasculariza- 
t ion (subgroup II, n - 41), CHF  with reversible ischemia 
(subgroup III, n = 55), and ventr icular arrhythmias re- 
sulting in sudden cardiac col lapse (n = 15) or syncope 
(n = 26) (subgroup IV, n = 41). Table II provides 
hemodynamic  and cchocard iographic  characterist ics of 
pat ients in each subgroup. Table III summarizes their  
preoperat ive medicat ions and cardiac support.  
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Table  I I I .  Preoperative medication and circulatory support 
Subgroup I Subgroup H Subgroup III Subgroup IV 
(n = 73) (n - 41) (n 55) (n = 41) 
Digoxin 5 5 38 12 
Diuretics 10 16 55 14 
ACE inhibitors Nil 4 26 6 
Phophodiesterase inhibitors Nil Nil 12 2 
Class I antiarrhythmic drugs 12 6 14 41 
Dopamine infusion 20 12 28 12 
IABP support 6 4 15 16 
ACE, Angiotensin-converting enzyme; IABP, intraaortic balloon pump. 
Table  IV. Operative characteristics of patients receiving antegrade versus retrograde (coronary sinus) 
cardioplegia 
Cardioplegia delivery 
Antegrade Retrograde 
Percent of 
Operative characteristics No. 210 No. % of 103 No. % of 107 P (X 2) 
Bypass > 150 min 90 43 49 48 41 38 0.2 
Crossclamp > 100 rain 101 48 55 53 46 43 0.1 
ITA used 41 19.5 25 24 16 15 0.1 
Four or more distal grafts 132 62.9 76 74 56% 52 0.001 
Mean bypass time (min) 123 _+ 2.6 116 + 1.8 
Mean crossclamp time (min) 88 -+ 2.1 80 +_ 2.1 
ITA, Internal thoracic artery. 
Management. Emergency CABG (within 6 hours of a 
cardiac catheterization) was performed in 44 patients 
(21% of 210); six had unstable angina (subgroup I) and 38 
had hemodynamic collapse (subgroup 4). Urgent CABG 
(between 6 and 48 hours) was performed in 100 patients 
(48%); 67 were in subgroup I, 15 in subgroup II, 15 in 
subgroup III, and 3 in subgroup IV. An intraaortic balloon 
pump was placed when, despite inotropic support, blood 
pressure was less than 90 mm Hg, cardiac index was less 
than 2.0 L/m 2, or LV end-diastolic pressure was greater 
than 20 mm Hg. All patients with known concomitant 
high-grade internal carotid stenosis (>85% on cerebral 
angiography) underwent simultaneous carotid endarterec- 
tomy and myocardial revascularization. Management of 
peripheral vascular lesions was by staged revasculariza- 
tion. In patients with end-stage renal disease, mainte- 
nance dialysis was resumed after myocardial revascular- 
ization. 
A thermodilution catheter was routinely placed before 
induction of anesthesia. Standard cardiopulmonary by- 
pass, moderate hypothermia (28 ° C), cold blood cardio- 
plegia, and topical cooling were used in all patients. 
Before September 1988, cardioplegic solution was usually 
delivered via the antegrade route. Since October 1988, 
combined antegrade and retrograde cardioplegia (via the 
coronary sinus) has been attempted on all patients in 
whom the risk was high (including those who met criteria 
for this study). Patients were not randomized as to the 
route of delivery of the cardioplegic solution. Of the 210 
patients in this study, 103 (48%) received antegrade 
cardioplegia only, and in 107 (51%), combined antegrade 
Table  V. Management of  patients with documented 
or suspected ventricular arrhythmias after CABG: 
ElectrophysioIogic testing (n = 72) 
Inducible sustained VT/VF (n 47) 
Pharmacologically resistant VT/VF (n = 17) 
1. AICD (n = 13) 
2. Endocardial blation (n = 4) (failure of AICD) 
VT/VF terminated by drugs (n - 30) 
1. Amiodarone (n = 12) 
2. Mexiletene (n = 6) 
3, Procainamide (n - 4) 
4. Encaide (n = 3) 
5, Mixed (n = 5) 
Noninducible VT/VF (n = 25) + other survivors (n = 107) 
Class I antiarrhythmic drugs as indicated 
VT/V~, Ventricular tachycardia/fibrillation; AICD, automatic implantable 
cardioverter-defibrillator. Survivors with preoperative VT/VF, n - 30/41; 
survivors with postoperative VT/VF, n - 14/23. All deaths occurred in 
patients who also had preoperative VT/VF. Survivors after sudden cardiac 
death in patients discharged after CABG, 7/9; syncope, n - 21. 
and retrograde cardioplegia was used. In three patients 
coronary sinus perfusion was attempted but was unsuc- 
cessful, and they received only antegrade cardioplegia 
(and are counted among the 103 "antegrade only" pa- 
tients). Tables I and IV list the preoperative and operative 
characteristics of the patients in the two cardioplegic 
delivery groups. 
Eighty-four patients (40%) required intraaortic balloon 
pump support for low cardiac output (preoperatively in
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Fig. 1A. Time-related survival after CABG in patients with preoperative jection fraction less than or 
equal to 20%. Circles represent individual deaths, positioned along the horizontal axis at the interval 
between operation and the time of death and, actuarially (Kaplan-Meier method), along the vertical axis. 
The vertical bars represent 70% confidence limits. Numbers in parentheses represent the number of patients 
continuing to be followed up after that time. The solid line represents he parametrically estimated survival, 
and the dashed lines enclose the 70% confidence limits of that estimate. The table provides parametric 
estimates at specified intervals. 
44, postoperatively in 40). Three patients required an LV 
assist device when placement of a balloon pump alone did 
not permit discontinuation of cardiopulmonary b pass. 
Only patients with recurrent angina underwent a second 
coronary angiography. 
There were 76 patients with a history (known or sus- 
pected) of ventricular arrhythmias. These patients include 
survivors of preoperative ventricular tachycardia/fibrilla- 
tion (VT/VF) (n = 30), those with documented postop- 
erative VT/VF (n - 14), patients with syncopal or presyn- 
copal episodes during follow-up (n - 25), and survivors of 
sudden cardiac ollapse requiring cardiopulmonary resus- 
citation (n = 7). Because these patients were at high risk 
for recurrent VT/VF, they underwent postoperative t st- 
ing: Holter monitor studies were performed in all patients 
and 72 (95%) underwent programmed electrophysiologic 
testing. Management was based on the results of testing as 
depicted in Table V. 
Follow-up. Perioperative information was obtained 
from hospital records. Complete cross-sectional follow-up 
(all 210 patients) was conducted between April 30 and 
June 30, 1994, by questionnaires, telephone conversations, 
and review of outpatient records. Among survivors, the 
interval from operation to last contact averaged 43 
months (_+ 17 months, 1 standard eviation), with a range 
of 15 to 86 months. 
Definitions: Unstable angina: Persistent anginal symp- 
toms with ST-T changes in the electrocardiogram neces- 
sitating nitroglycerin and heparin administration. 
Postinfarction angina: Persistent angina symptoms with 
ST-T changes in the same area where q waves appeared 
earlier, or evidence of extension of infarct on thallium 
scan. Angina and functional classification are as described 
by Goldman, Hashimoto, and Cook. 16 
Operable CAD. Stenosed vessels with internal diameter 
less than 1 ram, or with a diameter greater than 1 mm in 
the absence of diffuse or distal disease. Some patients with 
operable CAD, especially in subgroups II and III, did have 
inoperable vessels in some distributions (i.e., small vessels 
with diffuse distal disease). 
CHF: One or more episodes of fluid retention ecessi- 
tating diuretic therapy within 3 months of operation. 
Ischemic ardiomyopathy." Cardiac dilatation caused by 
ischemic myocardial degeneration.IV 
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Fig. lB. Hazard function for death after CABG. The hazard function has two phases, an early declining 
phase and a constant phase. The table provides hazard estimates at specified intervals. 
Monornorphic VT: VT with uniform QRS morphology 
in leads I, aVF, and V s. 
Polymorphic VT: VT with changes in axis (>45%) or 
altitude (>50%) or both. 
Sustained FT: Monomorphic or polymorphic VT lasting 
for more than 30 seconds with a heart rate greater than 
100 beats/rain. 
Standard electrophysiology protocol." A standard program 
of electrophysiologic stimulation used after antiarrhyth- 
mic medication was discontinued and cleared (at least 5 
half-lives). During the protocol, patients may have expe- 
rienced induced VF, defined as a disorganized rhythm with 
hemodynamic instability necessitating direct-current 
shock, or sustained induced VT/VF, defined as VT/VF 
lasting 30 seconds or more and necessitating termination 
of stimulation. 
LVstroke work index is stroke work index (mean arterial 
pressure - pulmonary capillary wedge pressure) × 0.0136 
gin/ram per square meter. 
Right ventricular stroke work index is stroke work index 
(mean pulmonary artery pressure - right atrial pressure) 
× 0.0136 gin/ram per square meter. 
Systemic vascular esistance index is (mean arterial pres- 
sure - right atrial pressure) × cardiac output × 80 
dynes • sec • cm -5. 
Statistical analysis. Values are expressed as mean _+ 
standard error of the mean or, when stated, _+ standard 
deviation. Univariate associations between concomitant 
variables and patient death were assessed by two-way 
contingency tables for discrete variables, by two-sample t 
test for continuous variables, and by logistic analysis for 
ordinal variables. Stratified Kaplan-Meier depictions ~s 
were used to explore time-related ifferences between 
subgroups of patients with various combinations ofpoten- 
tial risk factors. 
The time-related risk of death was modeled by means 
of a generic three-phase hazard method, a9 Hazard 
functions were also generated independently for the 
group of patients who received cardioplegic solution 
solely by the antegrade method and for those in whom 
cardioplegic solution was delivered by a combined 
antegrade/retrograde route. 
Determinants of postoperative d ath were identified by 
multivariate analysis, within each phase of hazard. Vari- 
ables listed in Table I were considered in the analysis. 
Transformations of scale for continuous and ordinal vari- 
ables were made to optimize their linear relationship in 
the logistic domain. During the process of developing a
parsimonious equation, variables were entered into the 
model sequentially by means of a direct, nonautomated 
technique. A maximum p value of 0.05 (likelihood ratio 
test) was accepted for retaining a variable in the model. 
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Fig. 2A. Time-related survival stratified by the route of cardioplegic delivery. The depiction is similar to 
that in Fig. 1A. 
Table VI. Incremental risk factors for death after CABG in patients with an ejection fraction <20% (n = 210; 
51 deaths) 
Hazard Phase 
Early Constant 
Risk factor Coefficient + SE p< Coefficient +_ SE p< 
Demographic 
Age (older) 
Clinical history 
Renal dysfunction 
Preoperative VT or VF 
Preoperative CHF 
Previous CABG 
Operative 
Nonuse of CS cardioplegia 
No. of distal anastomoses >-4 
Male (interaction) 
Female (interaction) 
0.07 -+ 0.023 0.004 
2.0 + 0.48 0.0001 
1.1 -+ 0.38 0.003 
0.7 -+ 0.39 0.05 
Intercepts -6 .7  + 1.7 <0.0001 
1.8 + 0.82 
2.6 -+ 0.88 
0.7 +- 0.38 
1.2 +- 0.34 
-11.4 -+ 2.1 
0.02 
0.004 
0.003 
0.0002 
<0.0001 
Log likeIihood- -234.51. 
Shaping parameters: O - 1.867; 6 = 0; v = 2.595; m 0. 
VT or VF, Ventricular tachycardia or fibrillation; CHF, congestive heart failure; CS, coronary sinus. 
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Fig. 2B. Hazard functions determined independently for the two routes of cardioplegic delivery. Note that 
the horizontal axis has been expanded to allow better visualization of early risk. The depiction is otherwise 
similar to that in Fig. lB. 
To illustrate the effect of individual risk factors, we 
generated nomograms ( pecific solutions of the multiva- 
riable equation) by solving the equation for different 
values of the variable of interest while simultaneously 
holding the value of all other variables constant. In 
graphic depictions, values are shown along with 70% 
confidence limits (± 1 standard eviation). 
Results 
Survival. There were 51 deaths (24% of 210). 
Twenty-one deaths occurred before hospital dis- 
charge (maximum postoperative stay was 45 days). 
Actuarial survival is depicted in Fig. 1A. The hazard 
function for death was biphasic, with an early de- 
clining and a later constant phase (Fig. 1B). Multi- 
variate analysis identified eterminates of postoper- 
ative survival, listed in Table VI. 
Survival was superior in patients who received 
combined antegrade and retrograde cardioplegia, 
versus antegrade only, because of a reduction in 
the risk of death early after operation (p = 0.05, 
Table VI, Figs. 2A and 2B). Actuarial survival in 
patients with preoperative VT/VF, identified as an 
early risk factor, is depicted in Fig. 3. Older age 
also increased early risk (p = 0.004), but its effect 
was weak and most pronounced when there were 
other risk factors. 
When the number of distal anastomoses was 
large, risk of death was higher in both men (p = 
0.003) and women (p = 0.0002). This negative 
association with survival was more pronounced in 
women than in men (p = 0.02, Fig. 4), and overall 
actuarial survival was higher in men (p = 0.04, Fig. 
4). Patients with preoperative CHF had decreased 
survival (Fig. 5), and in women with CHF, predicted 
5-year survival was only 20% (Fig. 5). 
Actuarial survival of patients, stratified by primary 
indication for operation (subgroups I to IV; see 
Methods) was not believably different (5-year sur- 
vival was 73% for subgroup I, 52% for subgroup II, 
55% for subgroup III, and 52% for subgroup IV; 
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parentheses represent the number of patients continuing to be followed up after that time. 
p = 0.4). However, by risk-adjusted analysis, pa- 
tients who had unstable angina (subgroup I) had the 
highest survival, because patients in all other sub- 
groups must, by definition, have one or more iden- 
tified risk factors. 
Of the 80 patients (40%) who required preoper- 
ative or postoperative balloon pump support, 26 
patients (33%) died. 
Vcntricular arrhythmias. Patients treated by the 
electrophysiologic protocol (those identified at in- 
creased risk for arrhythmic omplications) had a 
lower risk of sudden cardiac death (none vs 9) and 
greater actuarial freedom from postoperative 
VT/VF (83% vs 74% at 5 years), but these differ- 
ences could be due to chance alone (p = not 
significant, Fig. 6). 
Functional status. Among those alive at the time 
of cross-sectional follow-up, New York Heart Asso- 
ciation class was found to be lower than it was 
before the operation (preoperative 3.48 + 0.04 vs 
last contact 1.55 _+ 0.05;p = 0.005). 
Fifty patients had recurrent or progressive angina 
that required evaluation. The angina was severe in 
14 patients and mild or equivocal in 36. Angiogra- 
phy disclosed a correctable l sion in six patients (all 
with severe angina), and they eventually underwent 
successful angioplasty. Progressive ischemic ardio- 
myopathy developed in 16 patients, and four were 
listed for cardiac transplantation. 
Discussion 
Patient survival. Multiple studies have shown 
that patients with severe global LV dysfunction 
caused by CAD respond better with myocardial 
revascularization than with medical therapy 
alone.2, s, to, 15 Surgical intervention is known to be 
most beneficial in patients who are at highest risk 
with conventional medical therapy. 2° When patients 
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Fig. 4. Time-reIated survival stratified by gender. The depiction is similar to that in Fig. 3. 
have ischemic or acutely injured myocardium, 1' 16 
revascularization has been shown to prolong life 
expectancy, 21 improve functional status, 14'2° and 
diminish the prevalence of sudden cardiac deaths 
caused by arrhythmias, s' 10 Because cardiac trans- 
plantation is limited by donor supply (and many of 
these patients would make poor candidates owing to 
advanced age and coexistent diseases), surgical re- 
vascularization may offer the only chance for signif- 
icant improvement. 
In the past, perioperative mortality after CABG 
in patients with poor LV function has been reported 
to be between 10% and 37%, 1-3 but more recent 
reports indicate a much lower mortality (2.3% to 
5%), attributed to advances in myocardial manage- 
ment and surgical technique. 9'22-24 Studies have 
now documented 5-year survival after CABG ap- 
proaching 80%. 9, 15 
Myocardial protection. Studies indicate that 
blood cardioplegia is superior to asanguineous car- 
dioplegia I and that retrograde coronary sinus car- 
dioplegia may provide a more uniform myocardial 
protection in patients with severe multivessel dis- 
ease.25, 26 Our findings (although resulting from a 
nonrandomized xperience) are in support of these 
concepts. We found the risk of death among pa- 
tients who received retrograde cardioplegia to be 
lower, but only in the early postoperative period 
(Fig. 2B). These findings are consistent with the 
theory that retrograde delivery improves cardiople- 
gic protection, which may result in a critical im- 
provement in cardiac performance during the early 
postoperative period. 
Unfavorable patient characteristics. Increased 
perioperative mortality after CABG in patients with 
depressed LV function has previously been associ- 
ated with advanced age, female gender severity of 
CAD (left main disease, diffuse and multivessel 
CAD), inadequate myocardial protection, ventricu- 
lar irritability, and development or persistence of 
CHF after the operation. 1' 6 Our findings are con- 
sistent with these observations. 
In this series, 40% of patients were 70 years old or 
older and their perioperative mortality was 14%. 
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Risk-adjusted analysis confirmed advanced age as a 
risk factor for death early after operation (see Table 
VI), but with a weak coefficient, age alone was a 
poor predictor of 5-year survival. Only when other 
risk factors were present did the predicted 5-year 
mortality for a 70-year-old patient exceed 30%. 
These observations uggest hat in an otherwise 
healthy patient, CABG should not be denied solely 
on the basis of advanced age. 
Survival in medically treated patients with se- 
verely impaired LV function and congestive symp- 
toms has been reported to be as low as 18% at 5 
years. 5 Despite higher initial risk, CABG does im- 
prove symptoms and prolong survival when these 
patients have reversible ischemia and operable 
CAD .4, 6, 7, 14, 22, 27 Thus, although we have identi- 
fied CHF as a risk factor for death, CABG may 
substantially improve survival in many of these 
patients. 
Patients with grossly dilated ischemic ardiomy- 
opathy (LV end-diastolic dimension >70 ram) are 
poor candidates for CABG and are perhaps better 
treated by cardiomyoplasty or cardiac transplan- 
tation.28, 29 Dynamic cardiomyoplasty can improve 
LV function and CHF; however, because it re- 
quires more than 2 weeks of skeletal muscle 
preconditioning, it would be unsuitable in patients 
who require immediate therapy. 27' 2s 
The risk factors reported in this study provide for 
patient-specific estimates of survival. When multiple 
risk factors are present in a patient with minimal 
extracardiac disease, transplantation would likely be a 
better option. For example, a woman with diffuse 
distal disease or CHF may have a predicted 5-year 
survival of less than 20%. If this patient was an 
acceptable candidate, transplantation would be recom- 
mended. 
Ventricular arrhythmias. Ventricular arrhyth- 
mias are a common cause of sudden death in the 
natural history of patients with reduced ventricu- 
lar function. 2'10, 30-32 Even after successful revascular- 
ization, the risk of recurrence of arrhythmias is 
high,11,12 necessitating specific postoperative manage- 
ment. 
Preoperative and postoperative lectrophysi- 
ologic testing, to guide specific pharmacologic 
therapy, has been shown to reduce arrhythmic om- 
plications.S, 11-13, 22 In patients who have a pharma- 
cologically resistant condition, an implantable car- 
dioverter-defibrillator is recommended. 2%33-35 In 
this series, preoperative lectrophysiologic testing 
was not performed; however, selected patients had 
postoperative testing (see Methods) and were 
treated with specific antiarrhythmic medication or 
an implantable cardioverter-defibrillator (see Table 
V). Ideally, all patients hould have had preopera- 
tive electrophysiologically testing, directing place- 
ment of an implantable cardioverter-defibrillator or 
permanent implantable leads at the time of revas- 
cularization. 9 
Our results indicate that patients who were iden- 
tified at high risk for arrhythmic complications 
(those with sustained inducible ventricular arrhyth- 
mias) benefited from electrophysiologically guided 
management. None of the patients who receiving 
electrophysiologically guided management had a 
sudden cardiac death, and ventricular arrhythmias 
were less prevalent in this high-risk group than in 
the remaining patients (17% vs. 26%, p = not 
significant). When arrhythmic omplications did oc- 
cur after electrophysiologically guided treatment, 
they were probably due to the development of drug 
resistance. 
Some patients whose initial electrophysiologically 
studies were negative (without inducible sustained 
VT/VF) did have VT/VF during the follow-up pe- 
riod. Because arrhythmic omplications rarely occur 
when results of a recent electrophysiologically ex-
aminative are negative, 3°-3s periodic postoperative 
testing might have helped a few patients, but the 
cost of such a strategy would be prohibitive. In the 
near future, smaller endocardial pacing and defibril- 
lating systems, which can be placed percutaneously, 
may be an effective option for these patients. 36 
Conclusion 
CABG in patients with severely impaired LV func- 
tion appears beneficial if ischemia is reversible (sal- 
vageable myocardium) and the vessels are operable. 
Use of retrograde (coronary sinus) cardioplegia de- 
creases early mortality. A management s rategy that 
addressed congestive symptoms and ventricular ar- 
rhythmias resulted in acceptable survival. If character- 
istics associated with poor survival are identified, im- 
proved patient selection may be possible. An effective, 
timely revascularization with good myocardial protec- 
tion improves urvival in the early phase. 
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